Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Related Posts
Navigating Ineligibility Conversations with Clinical Trial Patients
Hugo Stephenson, MD, Co-Founder and Executive Chair, TrialScreen In clinical trials, every conversation with a patient carries weight, but few…
Registries as Sources of Regulatory-Grade Real-World Evidence (RWE)
February 3rd 2025 Article This white paper presents findings from the PurpleLab Migraine Study, which leverages real-world data to analyze…
Balancing DEI Reporting With Legal Risk
In a recent video interview with Applied Clinical Trials, Kate Gallin Heffernan, life sciences attorney, Epstein Becker Green, discussed the…